BLCO
Bausch + Lomb Corp.
NYSE · Healthcare · Medical - Instruments & Supplies · CA
$16.85
+0.48%Sep 15, 2026, 23:59 UTC
The US Food and Drug Administration issued a warning letter to Bausch and Lomb on 4 September over good manufacturing practice violations related to aseptic practices at its Tampa, Florida site.
Source:Aug 6, 2026, 11:04 UTC
Thomas J. Appio, CEO of Bausch Health, was appointed to the board of directors of Bausch + Lomb Corporation, effective August 5, 2026.
Source:Aug 6, 2026, 00:00 UTC
Four directors of Bausch & Lomb Corp resigned from the board effective August 5, 2026.
Jul 9, 2026, 21:12 UTC
Bausch + Lomb announced it will stop development of its glaucoma eye drop after the drug failed to meet the primary endpoint in a mid-stage trial.
Source:Jun 1, 2026, 10:59 UTC
Bausch + Lomb launched Blink Triple Care Preservative Free lubricant eye drops in the United States.
Source: